{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:07:54Z","timestamp":1793329674315,"version":"4.5.0"},"reference-count":54,"publisher":"Tottori University Faculty of Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Yonago Acta Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.33160\/yam.2018.09.001","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T22:48:41Z","timestamp":1552603721000},"page":"145-155","source":"Crossref","is-referenced-by-count":39,"title":["Role of Neuroimaging on Differentiation of Parkinson\u2019s Disease and Its Related Diseases"],"prefix":"10.33160","volume":"61","author":[{"given":"Toshihide","family":"Ogawa","sequence":"first","affiliation":[{"name":"Division of Radiology, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Fujii","sequence":"additional","affiliation":[{"name":"Division of Radiology, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Kuya","sequence":"additional","affiliation":[{"name":"Division of Radiology, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Kitao","sequence":"additional","affiliation":[{"name":"Division of Radiology, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shinohara","sequence":"additional","affiliation":[{"name":"Division of Radiology, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Division of Radiology, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Division of Radiology, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18656","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, et al.EFNS\/MDS-ES recommendations for the diagnosis of Parkinson\u2019s disease. Eur J Neurol. 2013;20:16-34. PMID: 23279440","DOI":"10.1111\/ene.12022"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Rizzo G, Copetti M, Arcuti S, Martino S, Fontana A, Logroscino G.Accuracy of clinical diagnosis of Parkinson\u2019s disease. a systematic review and meta-analysis. Neurology. 2016;86:566-76. PMID: 26764028","DOI":"10.1212\/WNL.0000000000002350"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Meijer FJ, van Rumund A, Fasen BA, Titulaer I, Aerts M, Esselink R, et al.Susceptibility-weighted imaging improves the diagnostic accuracy of 3T brain MRI in the work-up of parkinsonism. AJNR Am J Neuroradiol. 2015;36:454-60. PMID: 25339647","DOI":"10.3174\/ajnr.A4140"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Brooks DJParkinson\u2019s disease: diagnosis. Parkinsonism Relat Disord. 2012;Supp1:S31-33. PMID: 22166447","DOI":"10.1016\/S1353-8020(11)70012-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Blazejewska AI, Schwarz ST, Pitiot A, Stephenson MC, Lowe J, Bajaj N, Bowtell RW, et al.Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7T MRI. Neurology. 2013;81:534-40. PMID: 23843466","DOI":"10.1212\/WNL.0b013e31829e6fd2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Shimizu S, Hirao K, Kanetaka H, Namioka N, Hatanaka H, Hirose D, et al.Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2016;43:184-92. PMID: 26233438","DOI":"10.1007\/s00259-015-3146-y"},{"key":"7","unstructured":"7 Pahwa R, Lyons KE.Early diagnosis of Parkinson\u2019s disease: recommendations from diagnostic clinical guidelines. Am J Manag Care. 2010;16(Suppl):S94-S99. PMID: 20297872"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al.MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30:1591-601. PMID: 26474316","DOI":"10.1002\/mds.26424"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kalia LV, Lang AE.Parkinson\u2019s disease. Lancet. 2015;386:896-912. PMID: 25904081","DOI":"10.1016\/S0140-6736(14)61393-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Booth TC, Nathan M, Waldman AD, Quigley AM, Schapira AH, Buscombe J.The role of functional dopamine-transporter SPECT imaging in Parkinsonian syndromes, part 2. AJNR Am J Neuroradiol. 2015;36:236-44. PMID: 24924549","DOI":"10.3174\/ajnr.A3971"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Walker Z, Possin KL, Boeve BF, Aarsland D.Lewy body dementias. Lancet. 2015;386:1683-97. PMID: 26595642","DOI":"10.1016\/S0140-6736(15)00462-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Dabrowska M, Schinwelski M, Sitek EJ, Muraszko-Klaudel A, Brockhuis B, Jamrozik Z, et al.The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in the clinical practice. Neurol Neurochir Pol. 2015;49:421-31. PMID: 26652877","DOI":"10.1016\/j.pjnns.2015.10.002"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Martin-Macintosh EL, Broski SM, Johnson GB, Hunt CH, Cullen EL, Peller PJ.Multimodality imaging of neurodegenerative processes: part 2, atypical dementias. AJR Am J Rentogenol. 2016;Aug 9:1-13. [Epub ahead of print] PMID: 27504528","DOI":"10.2214\/AJR.14.12910"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Berg D, Lang AE, Postuma RB, Maetzler W, Deuschl G, Gasser T, et al.Changing the research criteria for the diagnosis of Parkinson\u2019s disease: obstacles and opportunities. Lancet Neurol. 2013;12:514-24. PMID: 23582175","DOI":"10.1016\/S1474-4422(13)70047-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Meijer FJ, van Rumund A, Tuladhar AM, Aerts MB, Titulaer I, Esselink RA, et al.Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism. Neuroradiology. 2015;57:655-69. PMID: 25845807","DOI":"10.1007\/s00234-015-1515-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kitao S, Matsusue E, Fujii S, Miyoshi F, Kaminou T, Kato S, et al.Correlation between pathology and neuromelanin MR imaging in Parkinson\u2019s disease and dementia with Lewy bodies. Neuroradiology. 2013;55:947-53. PMID: 23673875","DOI":"10.1007\/s00234-013-1199-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Cosottini M, Frosini D, Pesaresi I, Donatelli G, Cecchi P, Costagli M, et al.Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease. AJNR Am J Neuroradiol. 2015;36:461-6. PMID: 25376811","DOI":"10.3174\/ajnr.A4158"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19 Niccolini F, Politis M.A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism. Eur J Nucl Med Mol Imaging. 2016;43:2244-54. PMID: 27470326","DOI":"10.1007\/s00259-016-3464-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20 Lizarraga KJ, Gorgulho A, Chen W, De Salles AA.Molecular imaging of movement disorders. World J Radiol. 2016;8:226-39. PMID: 27029029","DOI":"10.4329\/wjr.v8.i3.226"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21 Broski SM, Hunt CH, Johnson GB, Morreale RF, Lowe VJ, Peller PJ.Structural and functional imaging in parkinsonian syndromes. RadioGraphics. 2014;34:1273-92. PMID: 25208280","DOI":"10.1148\/rg.345140009"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22 Mascalchi M, Vella A, Ceravolo R.Movement disorders: role of imaging in diagnosis. J Magn Reson Imaging. 2012;35:239-56. PMID: 22271273","DOI":"10.1002\/jmri.22825"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23 Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, et al.Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson\u2019s disease. Neuroreport. 2006;17:1215-8. PMID: 16837857","DOI":"10.1097\/01.wnr.0000227984.84927.a7"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24 Miyoshi F, Ogawa T, Kitao SI, Kitayama M, Shinohara Y, Takasugi M, et al.Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and 123I-metaiodobenzylguanidine scintigraphy. AJNR Am J Neuroradiol. 2013;34:2113-8. PMID: 23744697","DOI":"10.3174\/ajnr.A3567"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25 Kim JM, Jeong HJ, Bae YJ, Park SY, Kim E, Kang SY, et al.Loss of substantia nigra hyperintensity on 7Tesla MRI of Parkinson\u2019s disease, multiple system atrophy, and progressive supranuclear palsy. Parkinsonism Relat Disord. 2016;26:47-54. PMID: 26951846","DOI":"10.1016\/j.parkreldis.2016.01.023"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26 Kamagata K, Nakatsuka T, Sakakibara R, Tsuyusaki Y, Takamura T, Sato K, et al.Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosome versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study. Neuroradiology. 2017;59:89-98. PMID: 28035426","DOI":"10.1007\/s00234-016-1773-z"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27 Brigo F, Matinella A, Erro R, Tinazzi M.[123I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson\u2019s disease and vascular or drug-induced parkinsonism: a meta-analysis. Eur J Neurol. 2014;21:1369-76. PMID: 24779862","DOI":"10.1111\/ene.12444"},{"key":"27","unstructured":"28 Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx R.Statistical parametric mapping of 99mTc-ECD SPECT in idiopathic Parkinson\u2019s disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med. 2004;45:933-42. PMID: 15181127"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29 Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G.Perfusion ECD\/SPECT in the characterization of cognitive deficits in Parkinson\u2019s disease. Neurol Sci. 2001;22:45-6. PMID: 11487194","DOI":"10.1007\/s100720170039"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30 Paschali A, Messinis L, Kargiotis O, Lakiotis V, Kefalopoulou Z, Constantoyannis C, et al.SPECT neuroimaging and neuropsychological functions in different stages of Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging. 2010;37:1128-40. PMID: 20145921","DOI":"10.1007\/s00259-010-1381-9"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31 Amorim BJ, Camargo EC, Etchebehere EC.Regional CBF changes in Parkinson\u2019s disease: the importance of functional neuroimaging analyses. Eur J Nucl Med Mol Imaging. 2007;34:1455-7. PMID: 17437105","DOI":"10.1007\/s00259-007-0411-8"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32 Chow N, Aarsland D, Honarpisheh H, Beyer MK, Somme JH, Elashoff D, et al.Comparing hippocampal atrophy in Alzheimer\u2019s dementia and dementia with Lewy bodies. Dement Geriatr Cogn Disord. 2012;34:44-50. PMID: 22922563","DOI":"10.1159\/000339727"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33 Watson R, Blamire AM, Colloby SJ, Wood JS, Barber R, He J, et al.Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. Neurology. 2012;79:906-14. PMID: 22895591","DOI":"10.1212\/WNL.0b013e318266fc51"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34 Orimo S, Suzuki M, Inaba A, Mizusawa H.123I-MIBG myocardial scintigraphy for differentiating Parkinson\u2019s disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2012;18:494-500. PMID: 22321865","DOI":"10.1016\/j.parkreldis.2012.01.009"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35 Minoshima S, Foster NL, Sima AAF, Frey KA, Albin RL, Kuhl DE.Alzheimer\u2019s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol. 2001;50:358-65. PMID: 11558792","DOI":"10.1002\/ana.1133"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36 McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, et al.Diagnosis and management of dementia with Lewy bodies : third report of the DLB Consortium. Neurology. 2005;65:1863-72. PMID: 16237129","DOI":"10.1212\/01.wnl.0000187889.17253.b1"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37 Kantarci K, Lowe VJ, Boeve BF, Weigand SD, Senjem ML, Przybelski SA, et al.Multimodality imaging characteristics of dementia with Lewy bodies. Neurobiol Aging. 2012;33:2091-105. PMID: 22018896","DOI":"10.1016\/j.neurobiolaging.2011.09.024"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38 Sakamoto F, Shiraishi S, Yoshida M, Tomiguchi S, Hirai T, Namimoto T, et al.Diagnosis of dementia with Lewy bodies: diagnostic performance of combined 123I-IMP brain perfusion SPECT and 123I-MIBG myocardial scintigraphy. Ann Nucl Med. 2014;28:203-11. PMID: 24363079","DOI":"10.1007\/s12149-013-0796-3"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39 Graff-Radford J, Murray ME, Lowe VJ, Boeve BF, Ferman TJ, Przybelski SA, et al.Dementia with Lewy bodies: basis of cingulate island sign. Neurology. 2014;83:801-9. PMID: 25056580","DOI":"10.1212\/WNL.0000000000000734"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40 Miyoshi F, Kanasaki Y, Shinohara Y, Fujii S, Kaminou T, Tanabe Y, et al.Significance of combined use of MRI and perfusion SPECT for evaluation of multiple system atrophy, cerebellar type. Acta Radiol. 2016;57:742-9. PMID: 26253930","DOI":"10.1177\/0284185115598810"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41 Massey LA, Micallef C, Paviour DC, O\u2019Sullivan SS, Ling H, Williams DR, et al.Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord. 2012;27:1754-62. PMID: 22488922","DOI":"10.1002\/mds.24968"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42 Ling HClinical approach to progressive supranuclear palsy. J Mov Disord. 2016;9:3-13. PMID: 26828211","DOI":"10.14802\/jmd.15060"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43 Lee SE, Rabinovoci GD, Mayo MC, Wilson SM, Seeley WW, DeArmond SJ, et al.Clinicopathological correlations in corticobasal degeneration. Ann Neurol. 2011;70:327-40. PMID: 21823158","DOI":"10.1002\/ana.22424"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44 Doi T, Iwasa K, Makifuchi T, Takamori M.White matter hyperintensities on MRI in a patient with corticobasal degeneration. Acta Neurol Scand. 1999;99:199-201. PMID: 10100966","DOI":"10.1111\/j.1600-0404.1999.tb07345.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"45 Reim\u00e3o S, Pita Lobo P, Neutel D, Guedes LC, Coelho M, Rosa MM, et al.Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson\u2019s disease. Mov Disord. 2015;30:953-9. PMID: 25758364","DOI":"10.1002\/mds.26182"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46 Nicoletti G, Manners D, Novellino F, Condino F, Malucelli E, Barbiroli B, et al.Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor. Neurology. 2010;74:988-94. PMID: 20308683","DOI":"10.1212\/WNL.0b013e3181d5a460"},{"key":"46","doi-asserted-by":"crossref","unstructured":"47 Booth TC, Nathan M, Waldman AD, Quigley AM, Schapira AH, Buscombe J.The role of functional dopamine-transporter SPECT imaging in Parkinsonian syndromes, part 1. AJNR Am J Neuroradiol. 2015;36:229-35. PMID: 24904053","DOI":"10.3174\/ajnr.A3970"},{"key":"47","doi-asserted-by":"crossref","unstructured":"48 Lee PH, Kim JW, Bang OY, Joo IS, Yoon SN, Huh K.Cardiac 123I-MIBG scintigraphy in patients with essential tremor. Mov Disord. 2006;21:1235-8. PMID: 16671077","DOI":"10.1002\/mds.20908"},{"key":"48","doi-asserted-by":"crossref","unstructured":"49 Ziilmans J, Daniel SE, Hughes AJ, R\u00e9v\u00e9sz T, Lees AJ.Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord. 2004;19:630-40. PMID: 15197700","DOI":"10.1002\/mds.20083"},{"key":"49","doi-asserted-by":"crossref","unstructured":"50 Navarro-Otano J, Gaig C, Muxi A, Lome\u00f1a F, Compta Y, Buongiorno MT, et al.123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson\u2019s disease. Parkinsonism Relat Disord. 2014;20:191-7. PMID: 24252299","DOI":"10.1016\/j.parkreldis.2013.10.025"},{"key":"50","doi-asserted-by":"crossref","unstructured":"51 Bhogal P, Mahoney C, Graeme-Baker S, Roy A, Shah S, Fraioli F, et al.The common dementias: a pictorial review. Eur Raiol. 2013;23:3405-17. PMID: 24081643","DOI":"10.1007\/s00330-013-3005-9"},{"key":"51","doi-asserted-by":"crossref","unstructured":"52 Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al.Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734-46. PMID: 17616482","DOI":"10.1016\/S1474-4422(07)70178-3"},{"key":"52","doi-asserted-by":"crossref","unstructured":"53 Tolosa E, Borght TV, Moreno E.Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study. Mov Disord. 2007;22:2346-51. PMID: 17914722","DOI":"10.1002\/mds.21710"},{"key":"53","doi-asserted-by":"crossref","unstructured":"54 Kagi G, Bhatia KP, Tolosa E.The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry. 2010;81:5-12. PMID: 20019219","DOI":"10.1136\/jnnp.2008.157370"},{"key":"54","unstructured":"55 Stefanelli A, Treglia G, Bruno I, Rufini V, Giordano A.Pharmacological interference with 123I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice?. Eur Rev Med Pharmacol Sci. 2013;17:1326-33. PMID: 23740445"}],"container-title":["Yonago Acta Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yam\/61\/3\/61_2018.09.001\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T20:55:17Z","timestamp":1663102517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yam\/61\/3\/61_2018.09.001\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.33160\/yam.2018.09.001","relation":{},"ISSN":["1346-8049"],"issn-type":[{"value":"1346-8049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}